J Babol Univ Med Sci; 20(8); Aug 2018; PP: Received: Dec 24 th 2017, Revised: Mar 17 th 2018, Accepted: May 7 th 2018.

Similar documents
C ardiovascular disease (CVD) and stroke are the main causes of morbidity and

Improved Assessment of Aortic Calcification in Japanese Patients Undergoing Maintenance Hemodialysis

Vascular calcification in stage 5 Chronic Kidney Disease patients on dialysis

Cardiovascular Mortality: General Population vs ESRD Dialysis Patients

The impact of improved phosphorus control: use of sevelamer hydrochloride in patients with chronic renal failure

Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients

Effects of Kidney Disease on Cardiovascular Morbidity and Mortality

Protecting the heart and kidney: implications from the SHARP trial

The CARI Guidelines Caring for Australasians with Renal Impairment. Serum phosphate GUIDELINES

Review of Cardiac Imaging Modalities in the Renal Patient. George Youssef

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital

Calciphylaxis (cal-ci-phy-lax-is)

Normal kidneys filter large amounts of organic

David Ramenofsky, MD Bryan Kestenbaum, MD

( ) , (Donabedian, 1980) We would not choose any treatment with poor outcomes

Association of pelvic arterial calcification with arteriovenous thigh graft failure in haemodialysis patients

Title:Hyperphosphatemia as an Independent Risk Factor of Coronary Artery Calcification Progression in Peritoneal Dialysis Patients

OPEN. Masahiro Yoshikawa 1,2, Osamu Takase 1,2, Taro Tsujimura

Incorporating K/DOQI Using a Novel Algorithm Approach: Regina Qu Appelle s Experience

Nephrology Unit- CHU Liège- Ulg- Belgium

Advances in Peritoneal Dialysis, Vol. 29, 2013

Echocardiography analysis in renal transplant recipients

Month/Year of Review: September 2012 Date of Last Review: September 2010

Effects of Diabetes Mellitus, Age, and Duration of Dialysis on Parathormone in Chronic Hemodialysis Patients. Hamid Nasri 1, Soleiman Kheiri 2

Hyperphosphatemia is associated with a

Won Suk An 1,2 and Young Ki Son 1*

HTA ET DIALYSE DR ALAIN GUERIN

Ca, Phos and Vitamin D Metabolism in Pre-Dialysis Patients

Do We Do Too Many Parathyroidectomies in Dialysis? Sagar Nigwekar MD, MMSc Massachusetts General Hospital

CAD in Chronic Kidney Disease. Kuang-Te Wang

Diagnostic and Prognostic Value of Coronary Ca Score

Hemodialysis: slightly beyond basics Dialysate calcium and magnesium concentrations

CKD: Bone Mineral Metabolism. Peter Birks, Nephrology Fellow

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.

Screening for Cardiovascular Risk (2/6/09)

Secondary Hyperparathyroidism: Where are we now?

Klotho: renal and extra-renal effects

White Rose Research Online URL for this paper: Version: Accepted Version

A new era in phosphate binder therapy: What are the options?

Structural abnormalities of the heart and vascular system in CKD & Dialysis - Thick but weak

Randomized Clinical Trial of the Iron-Based Phosphate Binder PA21 in Hemodialysis Patients

Won Suk An Young Ki Son

IMPACT OF HCV THERAPY ON METABOLISM AND PUBLIC HEALTH

Report and Opinion 2016;8(12)

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

TREAT THE KIDNEY TO SAVE THE HEART. Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009

Left ventricular hypertrophy: why does it happen?

Morbidity & Mortality from Chronic Kidney Disease

CAROTID INTIMA-MEDIA THICKNESS. Dimitrios N. Nikas, MD, PhD, FESC Interventional Cardiologist Ioannina University Hospital

Psoriasi e rischio CV

Determinants of coronary artery calcification in maintenance hemodialysis patients

Role of High-sensitivity C-reactive Protein as a Marker of Inflammation in Pre-dialysis Patients of Chronic Renal Failure

Cardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center

Young patients with end-stage renal disease (ESRD) suffer

Title. CitationTransplantation Proceedings, 44(3): Issue Date Doc URL. Type. File Information

Clinical application of Arterial stiffness. pulse wave analysis pulse wave velocity

IMPLEMENTATION OF THE CKD-MBD PRACTICE. Goce Spasovski, R. Macedonia

TRANSPARENCY COMMITTEE OPINION. 22 July 2009

Takayasu disease Is it still a room for intervention? NO YES. BUT

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACTIVASE (t-pa) INFUSION PROTOCOL FOR ACUTE MYOCARDIAL INFARCTION

The CARI Guidelines Caring for Australasians with Renal Impairment. Biochemical Targets. Calcium GUIDELINES

RENAL TRANSPLANT PATIENTS WITH HIGH-FLOW AVF: WHEN & HOW TO INTERVENE Stuart Greenstein, MD Abdominal Organ Transplant Division Albert Einstein

Velphoro (sucroferric oxyhydroxide)

PATIENTS AND METHODS:

COGNITIVE ALTERATIONS IN CHRONIC KIDNEY DISEASE K K L E E

2.0 Synopsis. Paricalcitol Capsules M Clinical Study Report R&D/15/0380. (For National Authority Use Only)

Chapter 11. The Cardiovascular System. Clicker Questions Pearson Education, Inc.

Cardiovascular Implantable Electronic Device Leads & Arteriovenous Hemodialysis Access

Assessment of Arterials Functions: Is Pulse Wave Velocity ready forprime Time. Gérard M. LONDON INSERM U970 Hopital Georges Pompidou Paris, France

Setting the standard

Stefanos K. Roumeliotis. Department of Nephrology, Medical School Democritus University of Thrace, Alexandroupolis, Greece. Stefanos K.

Original epidemiologic studies 1 have suggested that approximately

Aortic CT: Intramural Hematoma. Leslie E. Quint, M.D.

Alma Mater Studiorum Bologna University. S.Orsola-Malpighi, Bologna, Italy Vascular Surgery

Elevated serum alkaline phosphatase and cardiovascular or all-cause mortality risk in dialysis patients: A meta-analysis

Therapeutic golas in the treatment of CKD-MBD

Cost of applying the K/DOQI guidelines for bone metabolism and disease to a cohort of chronic hemodialysis patients

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD

CKD FOR INTERNISTS. Dr Ahmed Hossain Associate professor Medicine Sir Salimullah Medical College

Renal function had an independent relationship with coronary artery calcification in Chinese elderly men

Measurement of vascular calcification using CT fistulograms

SCIENTIFIC DISCUSSION

RESUME Sep National Medical License, Taiwan Oct Board of Interal Medicine, Taiwan Aug Board of Cardiology, Internal Medicine, Taiwan

Cho et al., 2009 Journal of Cardiology (2009), 54:

proposed set to a required subset of 3 to 5 measures based on the availability of electronic

HYDROCHLORIDE FOR THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH END-STAGE RENAL DISEASE ON MAINTENANCE DIALYSIS THERAPY

Vitamin D receptor gene polymorphism and serum levels of Fetuin-A, Vitamin D and ipth in the hemodialysis patients

DECLARATION OF CONFLICT OF INTEREST. Nothing to disclose

For more information about how to cite these materials visit

Protocol GTC : A Randomized, Open Label, Parallel Design Study of Sevelamer Hydrochloride (Renagel ) in Chronic Kidney Disease Patients.

Month/Year of Review: May 2014 Date of Last Review: September New Drug Evaluation: Sucrofferic Oxyhydroxide (Velphoro )

Uroradiology For Medical Students

ENROLLMENT : Line of Business Summary

Impact of APD on Sleep

Cardiovascular Complications Of Chronic Kidney Disease. Dr Atir Khan Consultant Physician Diabetes & Endocrinology West Wales Hospital, Carmarthen

Effect of lanthanum carbonate and calcium acetate in the treatment of hyperphosphatemia in patients of chronic kidney disease

Fluid Resuscitation in Critically Ill Patients with Acute Kidney Injury (AKI)

Transcription:

Original Article J Babol Univ Med Sci Vol 20, Issu 8; Aug 2018. P:25-30 A Comparison of Abdominal Aortic Calcification Index (Aci) between Hemodialysis Patients and Control Group (Non-Diabetic, Non- Hypertensive Traumatic Patients) A. Peyro Shabani (MD) 1, M. Nabahati (MD) 2, R. Akbari (MD) 3,4, F. Oliaei (MD) 5 1.Student Research Committee, Babol University of Medical Sciences, Babol, I.R.Iran 2.Clinical Research Development Center, Shahid Beheshti Hospital, Babol University of Medical Sciences, Babol, I.R.Iran 3.Cellular & Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, I.R.Iran 4.Non-Communicable Pediatric Disease Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, I.R.Iran 5.Cancer Research Center, Health Research Institute, Babol University of Medical Sciences, Babol I.R.Iran ABSTRACT J Babol Univ Med Sci; 20(8); Aug 2018; PP: 25-30 Received: Dec 24 th 2017, Revised: Mar 17 th 2018, Accepted: May 7 th 2018. BACKGROUND AND OBJECTIVE: Calcification of media layer of peripheral arteries (Monkeburg sclerosis) often occurs with age and in diabetic patients with chronic renal failure. The appearance of this mark in hemodialysis patients can help predict cardiovascular events. Therefore, this study was conducted to compare the Abdominal Aortic Calcification Index (ACI) in hemodialysis and non-renal patients. METHODS: In this cross sectional study, 84 hemodialysis patients who had the inclusion criteria were enrolled. 157 traumatic patients who had no chronic diseases like diabetes or hypertension were enrolled as the control group. The evaluation of CT scan sections, put the patients in three ACI groups (0-40), (41-80) and (81-120). FINDINGS: A sum of 241 patients were enrolled in the study [ 84 (34.9%) in the case and 157 (65.1%) in the control group]. There was a significant difference in ACI between the two groups (P< 0.001). Comparing the chance of ACI in two groups, dialysis patients have a 22.67 times more chance to have severe ACI than mild ACI {CI 95% (4.987-103.062) (p=0.001)}, and also dialysis patients have a 7.32 times more chance to have severe ACI than moderate one {CI 95%(1.486-34.891) (p=0.001)}. CONCLUSION: According to more severe ACI in dialysis patients in comparison to healthy people, renal disease and dialysis may have an essential role in vascular calcification and its complications. KEY WORDS: Hemodialysis, Trauma, Vascular Calcification, Abdominal Aortic Calcification. Please cite this article as follows: Peyro Shabani A, Nabahati M, Akbari R, Oliaei F. A Comparison of Abdominal Aortic Calcification Index (Aci) between Hemodialysis Patients and Control Group (Non-Diabetic, Non-Hypertensive Traumatic Patients). J Babol Univ Med Sci. 2018; 20(8):25-30. Corresponding Author: F. Oliaei (MD) Address: Shahid Beheshti Hospital, Sargord Ghasemi Ave., Babol, I.R.Iran Tel: +98 32256285 E-mail: ol_1964@yahoo.com

26 A Comparison of Abdominal Aortic Calcification Index ; A. Peyro Shabani, et al Introduction Calcification in the blood vessels is one of the most common forms of dystrophic calcification that may occur in two different sites within the vascular wall, intima, and media (1). Calcification of media layer of peripheral arteries (Monkeburg sclerosis) often occurs with age and in diabetic patients with chronic renal failure. The appearance of this mark in hemodialysis patients can be helpful in predicting cardiovascular events (1,2). Media calcification reduces vascular compliance and the effect of hypertension and stress on myocardium and large vessels. Coronary artery disease is the end of a pathologic process characterized by calcification and stenosis, and no other treatment is definitive at this stage (3,4). The existence of a highly statistically significant association between ACI=Abdominal Aortic Calcification Index and the duration of hemodialysis on the one hand, and ACI and vascular events on the other hand in hemodialysis patients, according to the previous studies (1 and 2), now considered as undeniable principles. As far as the search is concerned, there is no direct comparison between ACI in hemodialysis patients and the healthy population of the community that does not have underlying disease such as diabetes and hypertension and chronic renal failure. Therefore, this study was performed to compare the calcification index of abdominal aorta in hemodialysis patients and those without kidney disease. group. In order to investigate the traumatic complications in the emergency department, they had an abdominal and hip CT scan without contrast that the abdominal aortic calcification index could be calculated as the control group. Patients undergoing dialysis for three months were included in the study. People with acute infection, known malignancy, active collagen vascular disease such as rheumatoid arthritis, and taking phosphate binder, such as renagel or aluminum hydroxide, during the test (in cases used these drugs, drugs must be discontinued at least one month before entering the study), dialysis period less than 3 months, diabetes, being treated with anticoagulants and having a history of para thyroidectomy or parathyroid dysfunction were excluded. Hemodialysis patients underwent axial CT scan without contrast on abdominal aorta. TACI was measured according to 10 sections of the abdominal aorta from the origin of renal arteries from the aorta to the abdominal aortic bifurcation. Each section of the aorta was divided into 12 sections. (Fig 1). Methods This cross-sectional study after approval by the Ethics Committee of Babol University of Medical Sciences with code MUBABOL.REC.1393.15 was performed on all hemodialysis patients of Shahid Beheshti Hospital in 2017. 84 hemodialysis patients underwent dialysis with lowflux polysulphone dialysers and dialysate calcium of 1.5 mmol/l in the last 3 months, 3 times a week for 4 hours have been enrolled in the group after receiving written consent. Among patients with trauma referring to Shahid Rajaee Hospital, Tonekabon, 157 patients age over 45 years, according to records (fasting blood glucose< 140, creatinine <1.4 and blood pressure< 140/90) without chronic underlying disease such as diabetes or hypertension and renal failure were entered as control Figure 1. Dividing the transverse section of the abdominal aorta into 12 sectors. In this image calcification is seen in 6 sectors At each point, the number of parts in which calcification was observed was counted and the number for each section was summed up with a number corresponding to 9 other sections (calcifications with HU> 100), and then the total number in each patient was calculated from 120 and the ACI score was obtained for each patient (5). The ACI was calculated by a person who was unaware of the problem and was only trained

J Babol Univ Med Sci; 20(8); Aug 2018 27 to do the job. ACI levels were divided into 3 groups: 0-40, 41-80, and 120-81. Similarly, ACI in traumatic patients in the control group was calculated and classified into the above three groups. To collect data, a checklist including age, sex and calcification index of abdominal aorta were collected. The Kolmogorov-Smirnov test was used to check the normal distribution of quantitative data. Chisquare test was used to analyze parametric data as well as odds ratio for comparing the chances of two groups to have ACI and p <0.05 was considered significant. Results A total of 243 patients (84 in the patient group and 159 in the control group) were studied. The mean age of the patients in the patient group was 50.15±16.93 years (range 18-83 years) and in the control group was 61.15±10.03 years old (range 87-45 years) (Table 1). There was a significant difference between the calcification level of abdominal aorta in both groups (p<0.0001). So that only two patients with trauma had an ACI score of between 81-120 (Fig 2). In different age groups, there was a significant difference between calcification of abdominal aorta in dialysis patients and traumatic patients (Table 2). In ACI examination, there was a significant difference in both men and women. Male and female dialysis patients had the highest calcification of abdominal aorta (Table 3). In terms of ACI odds in the two groups, dialysis patients had 22.67 times more chance of severe ACI versus mild ACI than traumatic patients in control group. (p=0.001), CI 95% (4.987-103.062). In addition, dialysis patients, compared to traumatic subjects (control), were 32.7 times more likely than ACI to have moderate ACI (p=0.001). CI 95% (1,486-34,891) Table 1. Basic information of patients in the two studied groups Groups Hemodialysis Traumatic Variables Age group (year) 50 51-70 71 41(48.8) 32(38.1) 11(13.1) 30(18.86) 102(64.15) 27(16.98) Gender Man Woman 46(54.8) 38(45.2) 109(68.55) 50(31.44) Figure 2. Distribution of abdominal aortic calcification in two groups Table 2. ACI examination in terms of age in dialysis and control patients Groups ACI age group Hemodialysis Traumatic 50 0-40 33(39.28) 30(18.86) 41-80 7(8.33) - 81-120 1(1.19) - 51-70 0-40 9(10.71) 92(57.86) 41-80 16(19.04) 8(5.03) 81-120 7(8.33) 2(1.25) 70< 0-40 2(2.38) 11(6.91) 41-80 2(2.38) 16(10.06) 81-120 7(8.33) - P-value

28 A Comparison of Abdominal Aortic Calcification Index ; A. Peyro Shabani, et al Table 3. ACI examination according to gender in dialysis and control patients Gender ACI Hemodialysis Traumatic P value Male Female 0-40 25(29.76) 93(58.49) 41-80 14(16.66) 14(8.8) 81-120 7(8.33) 2(1.25) 0-40 19(88.61) 40(25.15) 41-80 11(13.09) 10(6.28) 81-120 8(9.52) - Discussion This study showed that the calcification index of abdominal aorta (ACI) in dialysis patients is higher than those without kidney disease, diabetes or hypertension, and it is well known that hemodialysis or chronic renal failure is a risk factor for aortic calcification. Cerebral and cardiovascular events are the main cause of disability and mortality in patients with End-Stage Renal Disease (ESRD) (6). Vascular calcification is more prevalent in dialysis patients than healthy people, and its diagnostic tool varies in different locations (aorta, coronary and carotid) (9-7). Dialysis patients had more abdominal aortic calcification than traumatic patients. The ACI in traumatic patients was the most frequent in the range of 40-0, while in the range of 81-41 and 120-81, the incidence of dialysis patients was significantly higher. This simple, but highly significant statistical comparison shows well the hemodialysis role in increasing ACI in ESRD patients compared to control group, and, of course, its obvious association with vascular events in ESRD patients. In a study done by Block and colleagues, all patients had dialysis, and two types of phosphate binder had been used, a partial conclusion was made that 65% of coronary calcifications in dialysis were presented. This study did not have a healthy control group (10). There is also a positive and strong correlation between calcification of abdominal aorta and vascular events. In the study of Litwin et al., Intima Media Thickness (IMT) was compared in two healthy and CKD groups, and in the CKD group, more vascular damage was observed (11). In the study of Goodman et al., coronary calcification was compared in two groups of healthy and dialysis patients and the result was the same (12). Oh et al., in two groups of healthy and dialysis patients, using IMT measurements, Ct scan in carotid, reported a higher incidence of calcification in carotid of individuals with dialysis (13). The study of Huang et al. also suggested that calcification of abdominal aorta is associated with cardiovascular disease in peritoneal dialysis patients (14). OOn the other hand, the likelihood of patients with dialysis suffering from calcification of the heart valves is very high (15). However, in all of these studies, the relationship between increased vascular calcification (carotid, coronary) and CKD progression or dialysis is observed (which is also present in our study), but in none of these cases, the calcification of abdominal aorta between dialysed individuals and healthy subjects in terms of kidney problems, diabetes and blood pressure have not occurred. In several investigations calcification has also been associated with factors such as age, diabetes, myocardial infarction, hyperlipidemia, increased fibrinogen or serum CRP, or decreased albumin, hypertension and dialysis duration (2). Based on the results of this study, it was found that calcification index of abdominal aorta was significantly higher in patients undergoing chronic hemodialysis than in the control group (traumatic patients), which was representative of the population of normal people without the underlying disease, and this indicates the role of chronic hemodialysis (more than 3 months) in the increase in ACI in ESRD patients. The strengths and weaknesses of the study: The present study is the first study in relation to calcification of abdominal aorta,

J Babol Univ Med Sci; 20(8); Aug 2018 29 whose control arm is a population without underlying kidney disease or diabetes or blood pressure and this the strength of our study. As limitations of this study, because biochemical parameters such as Ca and P, Alk. P and ipth were not available in the control group, we were not able to compare these parameters between this group and the case group (hemodialysis patients). Meanwhile, the selection bias may have occurred in the control group. Acknowledgment Hereby, we would like to thank the collaboration of specialists in the radiology departments of Shahid Beheshti Hospital of Babol University of Medical Sciences and Shahid Rajaee hospital of Mazandaran University of Medical Sciences, Dr. Soodabeh Nikfarjam, Dr. Hamid Mehdizadeh and Amin Zarghami, and Ms. Sahareh Mehdi Nia and Mrs. Sakineh Kamali.

30 A Comparison of Abdominal Aortic Calcification Index ; A. Peyro Shabani, et al References 1.El Amrani M, Asserraji M, Rbaibi A, Salaheddine T, Benyahya M. 0433: Screening and risk factors of abdominal aortic calcifications in chronic hemodialysis: contribution of lateral abdominal X-ray. Arch Cardiovasc Dis Suppl. 2015;7(2):196. 2.Inuma J, Murakoshi M, Kobayashi T, Io H, Kaneko K, Takahashi T, et al. Relationship between acceleration plethysmography and aortic calcification index in chronic kidney disease patients. Hong Kong J Nephrol. 2012 10;14(2):48-53. 3.Imanishi K, Hatakeyama S, Yamamoto H, Okamoto A, Imai A, Yoneyama T, et al. Post-transplant Renal Function and Cardiovascular Events Are Closely Associated With the Aortic Calcification Index in Renal Transplant Recipients. Transplant Proceed. 2014;46(2):484-8. 4.Verbeke F, Vanholder R, Rensma PL, Wikström B, Jensen PB, Krzesinski J-M, et al. Role of aortic calcification, stiffness and wave reflections in cardiovascular risk in dialysis patients: Baseline data from the CORD study. Artery Res. 2010;4(3):81-90. 5.Tsushima M, Terayama Y, Momose A, Funyu T, Ohyama C, Hada R. Carotid intima media thickness and aortic calcification index closely relate to cerebro- and cardiovascular disorders in hemodialysis patients. Int J Urol. 2008;15(1):48-51. 6.Deguchi K, Izumi K, Noguchi M, Wada H, Shirakawa S. Response of the cubital vein to occlusion and calcification of the abdominal aorta in patients with chronic renal failure on maintenance hemodialysis. Thromb Res. 1988;49(1):69-77. 7.Lee YT, Ng HY, Chiu TT, Li LC, Pei SN, Kuo WH, et al. Association of bone-derived biomarkers with vascular calcification in chronic hemodialysis patients. Clinica Chimica Acta. 2016 1/15/;452:38-43. 8.Abdelmalek JA, Stark P, Walther CP, Ix JH, Rifkin DE. Associations Between Coronary Calcification on Chest Radiographs and Mortality in Hemodialysis Patients. Am J Kidney Dis. 2012;60(6):990-7. 9.Nitta K, Akiba T, Uchida K, Kawashima A, Yumura W, Kabaya T, et al. The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. Am J Kidney Dis. 2003;42(2):303-9. 10.Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int. 2005;68(4):1815-24. 11.Litwin M, Wuhl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, et al. Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol. 2005;16(5):1494-500. 12.Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342(20):1478-83. 13.Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation. 2002;106(1):100-5. 14.Huang JW, Lien YC, Yang CY, Liu KL, Wu CF, Yen CJ, et al. Osteoprotegerin, inflammation and dyslipidemia are associated with abdominal aortic calcification in non-diabetic patients on peritoneal dialysis. Nut Metab Cardiovasc Dis. 2014;24(3):236-42. 15.Hashemi J, Ggolshan A, Akaberi A. Relationship between biochemical risk factors for Atherosclerosis in dialysis patient and healthy persons. J North Khorasan Univ Med Sci. 2012;4(3):433-8.